Managing infertility with the follitropin alfa prefilled pen injector – patient considerations

References

• World Health OrganizationReproductive Health Indicators – Reproductive Health and Research Guidelines for Their Generation, Interpretation and Analysis for Global MonitoringGeneva, SwitzerlandWHO2006
   Google Scholar
• ChandraACopenCEStephenEHInfertility and Impaired Fecundity in the United States, 1982–2010: Data from the National Survey of Family Growth. National Health Statistics Reports; 67Hyattsville, MDNational Center for Health Statistics2013
   Google Scholar
• BühlerKBals-PratschMBlumenauerVDIR annual 2011 – German IVF-registryJ Reproduktionsmed Endokrinol20129456484
   Google Scholar
• MascarenhasMNFlaxmanSRBoermaTVanderpoelSStevensGANational, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveysPLoS Med2002912e100135623271957
   PubMedGoogle Scholar
• Department of HealthRegulated Fertility Services: A Commissioning Aid62009 Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_101068.pdfAccessed April 4, 2015
   Google Scholar
• LunenfeldBHistorical perspectives in gonadotrophin therapyHum Reprod Update20041045346715388674
   PubMed Web of Science ®Google Scholar
• DoniniPMontezemoloRRassegna di Clinica, Terapia e Scienze AffiniA publication of the Biologic Laboratories of the Instituto Serono194948328
   Google Scholar
• LunenfeldBTreatment of anovulation by human gonadotropinsInt J Obstet Gynecol19631153157
   Google Scholar
• van de WeijerBHMuldersJWBosESVerhaertPDvan den HoovenHWCompositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impuritiesReprod Biomed Online2003754755714680547
   PubMedGoogle Scholar
• Van DorsselaerACarapitoCDelalandeFDetection of prion protein in urine-derived injectable fertility products by a targeted proteomic approachPLoS One20116e1781521448279
   PubMed Web of Science ®Google Scholar
• Committee on Safety of MedicinesScientific Committee on Medicinal Products and Medical Devices Opinion on the Risk Quantification for CJD Transmission via Substances of Human Origin1998 Available from: http://ec.europa.eu/health/archive/ph_risk/committees/scmp/documents/out12_en.pdfAccessed April 4, 2015
   Google Scholar
• HowlesCMEzcurraDHomburgROvarian stimulation protocols in assisted reproductive technology: an updateExpert Rev Endocrinol Metab20127319330
   PubMedGoogle Scholar
• LehertPSchertzJCEzcurraDRecombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysisReprod Biol Endocrinol2010811212320846363
   PubMed Web of Science ®Google Scholar
• Yearbooks of the German IVF Registry DIR 1996–2002 Available from: http://www.deutsches-ivf-register.de/jahrbuch-archiv.phpAccessed April 30, 2015
   Google Scholar
• van WelyMKwanIBurtALRecombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles [review]Cochrane Database Syst Rev2011162CD00535421328276
   PubMedGoogle Scholar
• HowlesCMRole of LH and FSH in ovarian functionMol Cell Endocrinol2000161253010773387
   PubMed Web of Science ®Google Scholar
• BassettRLispiMCeccarelliDAnalytical identification of additional impurities in urinary-derived gonadotrophinsReprod Biomed Online20091930031319778474
   PubMed Web of Science ®Google Scholar
• LudwigMRabeTBühlerKDiedrichKFelberbaumREfficacy of recombinant human FSH in comparison to urinary hMG following a long Downregulation protocol – an analysis of 24764 ART cycles in GermanyJ Reproduktionsmed Endokrinol20041284288
   Google Scholar
• DriebergenRBaerGQuantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age?Curr Med Res Opin200319414612661779
   PubMed Web of Science ®Google Scholar
• HuguesJNBarlowDHRosenwaksZImprovement in consistency of response to ovarian stimulation with recombinant human follicle hormone resulting from a new method for calibrating the therapeutic preparationReprod Biomed Online2003618519012675998
   PubMedGoogle Scholar
• WiklandMHuguesJNHowlesCImproving the consistency of ovarian stimulation: follitropin alfa filled-by-massReprod Biol Endocrinol200612663668
   Google Scholar
• TredwayDFiszbajnGYekoTImprovement of clinical profile with Gonal-f Filled-by-Mass in ovulation induction (preliminary results from 1st treatment cycle)Presented at: VIIth FLASEF CongressMontevideo, UruguayNovember 18–21 2002F54
   Google Scholar
• BustilloMUnsuccessful oocyte retrieval: technical artefact or genuine ‘empty follicle syndrome’?Reprod Biomed Online20048596714759289
   PubMed Web of Science ®Google Scholar
• MarkleRLKingPJMartinDPKuttehWHKeRWCharacteristics of successful human chorionic gonadotropin (hCG) administration in assisted reproductionFertil Steril200278Suppl 17172
   Google Scholar
• PlatteauPLaurentEAlbanoCAn open, randomized single-centre study to compare the efficacy and convenience of follitropin β administered by a pen device with follitropin α administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSIHum Reprod2003181200120412773446
   PubMed Web of Science ®Google Scholar
• PorterRKisselCSaundersHKeckCPatient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pensCurr Med Res Opin20082472773518230195
   PubMed Web of Science ®Google Scholar
• WelckerJWNawrothFBilgerWPatient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational studyReprod Biol Endocrinol2010811111720843323
   PubMed Web of Science ®Google Scholar
• AbbottsCSalgado-BragaCAudibert-GrosCA redesigned follitropin alfa pen injector for infertility: results of a market research studyPatient Prefer Adherence2011531533121792303
   PubMed Web of Science ®Google Scholar
• IllingworthPJLahoudRQuinnFSingle-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatmentPatient Prefer Adherence2014881382624940048
   PubMed Web of Science ®Google Scholar
• ChristenMSchertzJCArriagadaPKeitelJMüllerHThe redesigned follitropin a pen injector for infertility treatmentExpert Opin Drug Deliv2011883383921548843
   PubMed Web of Science ®Google Scholar
• MoolenaarLMBroekmansFJvan DisseldorpJCost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic modelFertil Steril20119688986421868001
   PubMed Web of Science ®Google Scholar
• LandfeldtEJablonowskaBNorlanderBPatient preferences for characteristics differentiating ovarian stimulation treatmentsHum Reprod20122776076922240210
   PubMedGoogle Scholar
• DIR Deutsches IVF Register [homepage on the Internet] Available from: www.deutsches-ivf-register.deAccessed April 4, 2015 German
   Google Scholar